Paris, France

Elisabeth Traiffort

This inventor holds 7 USPTO granted patents, plus 2 CIPO patents and 4 EPO patents. Top assignees: Centre National De La Recherche Scientifique, M Et P Pharma Ag, Universitéde Strasbourg. Active years: 2007-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elisabeth Traiffort. Retrieved from https://idiyas.com/inventor/elisabeth-traiffort

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 42.9


 

Average Co-Inventor Count = 3.8

ph-index = 2

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 2007-2023

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Elisabeth Traiffort: Innovator in Demyelinating Disease Treatments

Introduction

Elisabeth Traiffort is a prominent inventor based in Paris, France. She has made significant contributions to the field of medicine, particularly in the treatment of demyelinating diseases. With a total of 7 patents to her name, her work has garnered attention for its innovative approaches and potential impact on patient care.

Latest Patents

Among her latest patents, Elisabeth has developed methods for promoting remyelination in subjects suffering from demyelinating diseases. These methods involve administering a combination of steroid hormones and Hedgehog signaling pathway modulators. Additionally, she has described methods for administering this combination of drugs in compositions adapted for nasal administration. This innovative approach could provide new avenues for treatment in patients affected by these challenging conditions.

Career Highlights

Elisabeth has worked with esteemed organizations such as the Centre National de la Recherche Scientifique and M Et P Pharma AG. Her experience in these institutions has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.

Collaborations

Elisabeth has collaborated with notable colleagues, including Martial Ruat and Claudia Mattern. These partnerships have further enriched her research and development efforts, leading to advancements in the treatment of demyelinating diseases.

Conclusion

Elisabeth Traiffort's innovative work in the treatment of demyelinating diseases highlights her dedication to improving patient outcomes. Her contributions to the field through her patents and collaborations demonstrate her commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…